Yannis Karamanos, male, biochemist, Ph.D. at the biochemistry department, Lille University in 1983. He worked for Biotechnology Institute, Limoges University 1987-1996. Professor in 1996 he created the Laboratory for Molecular and Cellular Biochemistry at Artois University 1996-2000, before to merge with the Blood-Brain Barrier Laboratory (BBB Lab), directed by Professor Roméo Cecchelli at Artois University in 2001. From 1980 to 2000 he worked on the structure-function relationships of glycoconjugates and his main project was the investigations on the biological roles of the de-N-glycosylation enzymes (Endo-N-acetyl-beta-D-glucosaminidase and peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase). From 2002 he developed the proteome project of the BBB Lab. He has published more than 60 papers and participated at numerous international conferences. From 2013 he developed innovative teaching practices and adopted the Scholarship of Teaching and Learning (SoTL) concept.

Research scientist in genome and cancer biology and expert in science sustainability

Our lab uses genetically modified mouse models and a combination of cell biology, molecular biology, and biochemistry techniques to study the role of altered mitochondrial dysfunction and metabolism in human diseases. A primary analytical tool of the group is metabolomics, which enables the parallel quantification of hundreds of small molecule metabolites. The team also uses computational approaches to integrate datasets from multi-dimensional analyses, including metabolomics, proteomics, and transcriptomics, with the aim to model aging-related disorders and to generate mechanistic hypotheses that will be cross validated experimentally.

Launched in 2011, FEBS Open Bio is an online-only open access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal's peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.

The FEBS Junior Section is organised by students and young researchers from some FEBS Constituent Societies. They develop joint activities, such as online talks and other events, and share resources, as well as open doors for young European scientists to opportunities outside their home countries by providing the relevant contacts and fostering communication within the network.

Atherosclerosis, inflammatory diseases, biomarkers

biochemistry, molecular biology, bioinformatics, molecular visualisation, technology for teaching and learning

Dr. Isabel Varela-Nieto graduated and earned her doctorate in Chemistry, Biochemistry Section, at the University Complutense of Madrid (Spain). She has been a visiting guest scientist at the Medical Schools of Uppsala (FEBS Fellow, Sweden) and San Diego (MEC Sabbatical, USA). She is Professor of Research at the CSIC and group leader at the CIBER of rare diseases (CIBERER, ISCIII) in Madrid. From the early 1990s she has been studying hearing neurobiology and IGF-1 actions. She was the first Chair of the SEBBM Science for Society working group with which she actively collaborates, and member of the FEBS Network working group. She is currently the president of the SEBBM, a member of the FEBS Science and Society Committee and of the ISC Finances Committee.

Ex-academia, now in MedComms. I write a blog called Total Internal Reflection about the human side of science. Postings are generally either opinion/commentary (either serious or silly) or "How To" pieces aimed at improving young scientists' soft skills.  A longer biography and manifesto are on the blog here.

Organelle biogenesis, peroxisomes, yeast